Yahoo Web Search

Search results

  1. Feb 6, 2024 · Dr. Schneider received his Ph.D. in Organic Chemistry from Texas A&M University with Jeffery Kelly and then went on to the University of Pennsylvania School of Medicine, Department of Biochemistry and Biophysics where he was a George W. Raiziss Fellow with William DeGrado studying protein design.

  2. Articles 1–20. ‪National Cancer Institute‬ - ‪‪Cited by 16,504‬‬ - ‪soft materials‬ - ‪drug delivery‬ - ‪self-assembly‬ - ‪cell-penetrating peptides‬ - ‪peptide design synthesis &...

  3. Senior Investigator. Head, Peptide Design and Materials Section. CCR Deputy Director. RESEARCH SUMMARY. The Schneider group designs and characterizes novel materials for use in drug delivery, the delivery of cells, and antibacterial therapy. Areas of Expertise. Cancer Drug Discovery. Soft Materials. Drug Delivery. Self-Assembly.

  4. I am a researcher who loves to leverage the stories and experiences of stakeholders to improve outcomes, tackle pressing research challenges, promote equity and justice, empower others, and challenge ineffective or oppressive systems.

  5. Joel P. Schneider. Broad size distributions and poor long‐term colloidal stability of microRNA‐carrying nanoparticles, especially those formed by polyelectrolyte complexation, represent major...

  6. Currently, he serves as the Chief of Chemical Biology and Deputy Director of Basic Science in the Center for Cancer Research, NCI. Dr. Schneider's lab develops injectable hydrogel materials, bioadhesives, and cellular delivery vehicles capable of administering therapeutics locally to tissue.

  7. Majumder P, Singh A, Wang ZQ, Dutta K, Pahwa R, Liang C, Andrews C, Patel NL, Shi JF, de Val N, Walsh STR, Jeon AB, Karim B, Hoang CD, Schneider JP. Surface-fill hydrogel attenuates the oncogenic signature of complex anatomical surface cancer in a single application.